During the past decade, Novosibirskiy Gastrocenter conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novosibirskiy Gastrocenter" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "GB004, Inc." with 1 trials sponsored and "Immunic AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novosibirskiy Gastrocenter" #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Novosibirskiy Gastrocenter" are "Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (1 trials) and "Moderate to Severe Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Novosibirskiy Gastrocenter" in a lesser frequency.

Most popular intervention types in "Novosibirskiy Gastrocenter" are "Drug" (15 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Mirikizumab" (3 trials), "Ozanimod" (3 trials), "PF-06651600" (2 trials) and "PF-06700841" (2 trials). Other intervention names were less common.

The vast majority of trials in "Novosibirskiy Gastrocenter" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Novosibirskiy Gastrocenter". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Novosibirskiy Gastrocenter, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Novosibirskiy Gastrocenter, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".